The Health Department on April 17 issued an urgent safety notification to all healthcare facilities across Papua New Guinea regarding counterfeit OxyContin 80 mg tablets discovered in Switzerland’s unregulated market, following a similar alert from the World Health Organization (WHO). The genuine manufacturer, Mundipharma, initially reported the issue to the WHO in February this year....
Unlock this article with Premium. To access all premium content, contact us at [email protected]
Already a member? Log in here
